10 1 paraneoplastic syndromes (1)

Upload: teky-widyarini

Post on 02-Jun-2018

254 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    1/31

    Paraneoplastic

    Syndromes

    Krzysztof RonowskiClinic of Oncology

    Pozna University of Medical Sciences

    Elective Course in Oncology for Medical

    Students

    18.08.2011

    Pozna, Poland

    http://www.ump.edu.pl/pol/?department=12
  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    2/31

    Paraneoplastic Syndromes

    - Different symptoms or pathological

    disorders not directly caused by the

    presence of malignant disease

    - Distal manifestation from the primary

    localization of the neoplasm or its

    metastases

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    3/31

    Paraneoplastic syndromes are

    observed in the course of more

    than 15% of all cases ofmalignant diseases

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    4/31

    Diagnosis of paraneoplastic

    syndromes

    Different pathological situations, like

    chronic organs insufficiency,

    infections, endocrine disorders cangive similar symptoms

    Diagnosis of paraneoplastic syndromesis diagnosis of exclusion other

    diseases

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    5/31

    Clinical appearance of

    paraneoplastic syndromes

    Symptoms preceding clinicalmanifestation of neoplasm

    Symptoms co-existing with signs ofactive malignancy

    Symptoms observed after failure oftreatment, present in late stages ofadvanced/metastatic disease

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    6/31

    Establishing diagnosis ofparaneoplastic syndromes

    appearing before manifestation

    of malignant disease could beessential for early detection of

    neoplasm

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    7/31

    Therapeutic approach

    Effective treatment of malignant

    disease

    Symptomatic treatment

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    8/31

    Classification of paraneoplastic

    syndromes

    Common classification based on the

    most affected tissue, organ or system

    Classification according to mechanism

    of initiation particular symptoms andsyndromes

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    9/31

    Classification of paraneoplastic

    syndromes cont.

    Two basic mechanisms of appearance ofparaneoplastic syndromes:

    - endocrine, as a result of excretion ofhormones, hormone related peptides orcytokines

    - autoimmunological, as a consequence ofantigen similarity between malignant andnormal tissues

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    10/31

    Endocrinological manifestations

    of neoplasmatic diseases Inappropriate secretion of antidiuretic hormone

    hyponatremia

    Ectopic secretion of PTH or PTHrP hypercalcemia

    Ectopic secretion of ACTH and ACTH-likesubstances Cushings syndrome

    Hypoglycemia as a result of ectopic secretion ofinsulin-like growth factor t.II

    Gonadotropins (example gynecomastia caused by

    germ cell tumors secreting beta-hCG)

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    11/31

    Hematological paraneoplastic

    syndromes

    Erythrocytosis due to secretion oferythrtopoetin or/and cytokines enhancingits effect (renal carcinoma, hepatoma,phoechromocytoma)

    Anemia the most common is normocyticanemia of chronic disease, but also observed

    autoimmune hemolytic anemia in the courseof limphoid malignances or microangiopaticanemia

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    12/31

    Hematological paraneoplastic

    syndromes cont.

    Granulocytosis associated with ectopicsecretion of G-CSF and GM-CSF,

    observed in lymphoid malignanciesand tumors of digestive tract

    Eosinophilia caused by tumor-associated eosinophil-stilmulatingfactor (glycoprotein of 45kd) producedby Hodgkins cells

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    13/31

    Hematological paraneoplastic

    syndromes cont.

    Coagulopathies

    Disseminated IntravascularCoagulation (DIC) as an effect ofthrombocytopenia, hypofibrinogenemiaand activation of fibrinolisis; requiringboth effective anti-cancer therapy andsymptomatic therapy as life-threateningstatus

    P l ti d

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    14/31

    Paraneoplastic syndromes

    connected with nutrition and

    digestive system

    Anorexia misperception of signals infeeding centre caused by inadequate level of

    serotonin due to secretion of differentcytokines (TNF, IL1, IL6) by cancer cells

    Protein losing enteropathy

    Hypercatabolism stimulated by TNF- alfa, IL1,IL6 and other cytokines observed mainly in

    muscle and fat tissue

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    15/31

    Paraneoplastic syndromes

    connected with nutrition cont

    Cachexia as a result of anorexia and

    increased catabolism paraneoplasticsyndrome often observed in advanced

    stages of malignant diseases after

    failure of anticancer treatment; requiressymptomatic treatment for quality of

    life improvement

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    16/31

    Nephrological paraneoplastic

    syndromes

    Acute and chronic glomerulonephritisas a result of autoimmunological

    reaction against elements of kidneysglomeruli

    Renal failure due to precipitation ofureic acid, pathological proteins orcalcium in the course of paraneoplasticmetabolic disorders

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    17/31

    Cutaneous paraneoplastic

    syndromes

    Effect of autoimmunological reactionsagainst different dermal and epidermal

    structures

    Often preceding manifestation ofmalignancy

    Proper diagnosis may lead to earlydetection of cancer

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    18/31

    Cutaneous paraneoplastic syndromes

    cont.

    Leser - Trelat syndrome - diffuse seborhoic papillomatosisaffecting mainly trunk; early sign of many malignancies

    especially deriving form gastro-intestinal tract; caused by

    secretion of TGF and overexpression of EGFR

    http://morningreporttgh.blogspot.com/2009/05/less-is-more.html

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    19/31

    Cutaneous paraneoplastic syndromes

    cont.

    Sweet syndrome lupus-like, painful spots localizedon face and neck appearing sometimes few yearsbefore manifestation of lymphoid malignancies

    http://dermatology.cdlib.org/DOJvol5num1/therapy/sweets.html

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    20/31

    Cutaneous paraneoplastic syndromes

    cont.

    Dermatology Online Journal 10 (1): 21

    Paraneoplastic acrokeratosis

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    21/31

    Cutaneous paraneoplastic syndromes

    cont.

    Pemphigus result of

    autoimmunological reaction against

    desmosomes

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    22/31

    Cutaneous paraneoplastic syndromes

    cont.

    Dermatitis herpetiformes localized on knees, elbows

    and lumbar region early manifestation of small

    bowl lymphomas

    Pruritis- one of general symptoms of hematological

    malignancies as an effect of IL1, IL6 and TNF

    secretion by lymphoid malignant cells or/and

    activated lymphocytes T infiltrating different solid

    tumors

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    23/31

    Osteoarticular and muscle systems

    paraneoplastic syndromes

    Hypertrophic osteoarthropathy digitalclubbing, periostitis of tubular bone, generalized arthritis,

    syndrome observed in the course of many solid tumors,

    requiring besides primary treatment also effective symptomatic

    treatment with steroids and non-steroid anti-inflammatory

    drugs

    http://cancergrace.org/lung/2009/02/10/hpoa/

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    24/31

    Osteoarticular and muscle systems

    paraneoplastic syndromes

    Palmar Fasciitis and Polyarthritis

    From medal.org, the largest collection of medical algorithms,

    Institute of Algorithmic Medicine Under License to Medal.org Ltd

    http://www.medal.org/http://www.medal.org/
  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    25/31

    Osteoarticular and muscle systems

    paraneoplastic syndromes cont.

    Myositis(ovarian cancer, NHL, thyroid cancer

    http://www.radiologyassistant.nl/en/4ae30bb452e53

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    26/31

    Neurological paraneoplastic

    syndromes

    Antigen similarity between malignant and nervoustissue causing autoimmunological reactions e.g.against myelin associated glycoprotein (MAG)

    Acute or subacute inflammations often ofprogressive, degenerative and irreversible character

    Often preceding manifestation of neoplasm,diagnosis difficult to establish, resistant for any kindof therapy; diagnosis of malignant disease is setoften during autopsy after non effective treatment ofneurological disorders

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    27/31

    Neurological paraneoplastic

    syndromes cont.

    Paraneoplastic cerebellar degeneration

    subacute inflammatory- degenerative process in Purkynys cells,

    leading to ataxia, dysartria, progressing dementia; difficult todiagnose- MRI and CT scans non specific, sometimes elevated level

    of IgG in cerebrospinal fluid; without effective treatment of

    underlying malignancy lethal character of this syndrome

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    28/31

    Paraneoplastic cerebellar

    degeneration

    http://www.penncancer.org/pnd/subpage

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    29/31

    Neurological paraneoplastic

    syndromes cont.

    Retinal degeneration

    Paraneoplastic opsoclonus-myoclonus

    Limbic encephalitis

    Sensory and motor neuropathy

    Sensimotor peripheral neuropathy

    Pseudomiastenic Lambert Eaton syndrome (small celllung cancer)

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    30/31

    Miscellanenous Paraneoplastic

    Syndromes

    Fever one of general symptoms oflymphoid malignances; influence ofinterleukines on metabolism of arachidonic

    acid leading to increased level ofprostaglandin E2, which stimulatesthermoregulatory centre;

    In case of solid tumors the same effectachieved by elevated level of interferons andTNF produced by healthy cells as a result ofpresence of malignant tissue

  • 8/10/2019 10 1 Paraneoplastic Syndromes (1)

    31/31

    Paraneoplastic Syndromes

    Knowledge of symptoms and syndromes not directlyconnected with primary site of malignant tumor isimportant for its early detection

    Resolution of paraneoplastic syndromes may be aprognostic factor in assessment of efficacy ofanticancer treatment

    The best mode of treatment of paraneoplasticsyndromes is effective treatment of malignantdisease but for improvement of quality of patientslife, they sometimes require symptomatic treatment